Keyphrases
Parallel Sequencing
100%
Guinea-Bissau
100%
Molecular Markers
100%
Malaria Rapid Diagnostic Test
100%
Rapid Diagnostic Test
100%
Plasmodium
60%
Library Preparation
60%
Pfmdr1
40%
Pfdhfr
40%
DNA Content
40%
Molecular Surveillance
40%
Pfcrt
40%
Pfdhps
40%
Two-site
20%
Demographic Data
20%
Custom Design
20%
Plasmodium Falciparum
20%
Amplicon
20%
Routine Care
20%
Targeted Sequencing
20%
Pre-screening
20%
Clinical Material
20%
Antimalarial Drug Resistance
20%
Parasite DNA
20%
Lack of Infrastructure
20%
Codon
20%
Patient Data
20%
Parasitemia
20%
PCR Positivity
20%
Political Instability
20%
DNA Extraction
20%
Leftovers
20%
Older Adults
20%
MiSeq
20%
Gene Fragments
20%
Illumina MiSeq
20%
Polymorphism
20%
Plasmodium Infection
20%
Flow Cell
20%
Health Centers
20%
Biochemistry, Genetics and Molecular Biology
Antimalarial Drug Resistance
100%
Genetic Marker
100%
Plasmodium
100%
DNA Content
66%
Clinical Study
33%
Amplicon
33%
Illumina MiSeq
33%
Haplotype
33%
Plasmodium falciparum
33%
Efficacy Study
33%
DNA Extraction
33%
Patient Coding
33%
Parasitemia
33%
Codon
33%
Immunology and Microbiology
Genetic Marker
100%
Antimalarial Drug Resistance
100%
Plasmodium
100%
DNA Content
66%
Illumina MiSeq
33%
Parasitemia
33%
Haplotype
33%
Patient Coding
33%
Codon
33%
Plasmodium falciparum
33%
DNA Extraction
33%
Amplicon
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Agent
100%
Plasmodium
100%
Molecular Marker
100%
Clinical Study
33%
Drug Resistance
33%
Efficacy Study
33%
Combination Therapy
33%
Infection
33%
Parasitemia
33%
Malaria Falciparum
33%
Plasmodium falciparum
33%
Artemisinin
33%
Medicine and Dentistry
Antimalarial Drug Resistance
100%
Molecular Marker
100%
Rapid Diagnostic Test
100%
Plasmodium
42%
Malaria Falciparum
14%
Clinical Study
14%
DNA Extraction
14%
Plasmodium falciparum
14%
Efficacy Study
14%
Illumina MiSeq
14%
Haplotype
14%
Codon
14%
Amplicon
14%
Artemisinin
14%
Infection
14%
Patient-Data
14%
Parasitemia
14%
Combination Therapy
14%